August 2, 2022 —   The American College of Radiology (ACR) Center for Research and Innovation (CRI) will serve as the operations center for the new Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) announced August 1 at the Alzheimer’s Association International Conference (AAIC) 2022.

ACR Neuroradiology Research Committee Chair Christopher T. Whitlow, MD, PhD, MHA, is a co-investigator for ALZ-NET, which will collect long-term clinical and safety data from patients treated with FDA-approved Alzheimer’s disease (AD) therapies. 

ACR CRI will also provide guidance, education and best practices in imaging care for dementia and AD patients. Imaging serves a pivotal role in AD diagnosis and routine safety monitoring of AD therapy patients. 

Clinical dementia care sites will participate directly in ALZ-NET. Imaging facilities will provide optimal imaging care to patients and thorough reporting to treating clinicians. 

ALZ-NET partner organizations include the Alzheimer's Association, the ACR, Critical Path Institute, Department of Biostatistics at Brown University School of Public Health and the American Society of Neuroradiology, along with other clinical research and imaging experts. 

For more information: https://www.acr.org/Research/Clinical-Research/ALZNET 

Related Alzheimer's Content: 

Research Suggests Specialized Brain Imaging can Unveil Mysteries of Alzheimer’s Disease, Other Disorders 

FDA Grants Accelerated Approval for Alzheimer’s Drug Aduhelm 

VIDEO: Researchers Use MRI to Predict Alzheimer's Disease 

Brain Iron Accumulation Linked to Cognitive Decline in Alzheimer's Patients 

Good Results for Alzheimer’s Imaging Agent 

NIH Augments Large Scale Study of Alzheimer’s Disease Biomarkers 

Alzheimer’s Association Launches New Website for IDEAS Study 

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment